{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,19]],"date-time":"2026-04-19T07:53:09Z","timestamp":1776585189636,"version":"3.51.2"},"publisher-location":"New York, NY","reference-count":28,"publisher":"Springer US","isbn-type":[{"value":"9781071634721","type":"print"},{"value":"9781071634738","type":"electronic"}],"license":[{"start":{"date-parts":[[2023,10,12]],"date-time":"2023-10-12T00:00:00Z","timestamp":1697068800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,10,12]],"date-time":"2023-10-12T00:00:00Z","timestamp":1697068800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024]]},"DOI":"10.1007\/978-1-0716-3473-8_16","type":"book-chapter","created":{"date-parts":[[2023,10,11]],"date-time":"2023-10-11T10:06:16Z","timestamp":1697018776000},"page":"233-239","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Emerging In Vitro Models for the Study of Infection and Pathogenesis of Pseudomonas aeruginosa and Testing of Antibacterial Agents"],"prefix":"10.1007","author":[{"given":"Tarcisio","family":"Brignoli","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Silvia","family":"Ferrara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giovanni","family":"Bertoni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,10,12]]},"reference":[{"key":"16_CR1","doi-asserted-by":"publisher","unstructured":"Wood SJ, Kuzel TM, Shafikhani SH (2023) Pseudomonas aeruginosa: infections, animal modeling, and therapeutics. Cell 12:199. https:\/\/doi.org\/10.3390\/cells12010199","DOI":"10.3390\/cells12010199"},{"key":"16_CR2","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1111\/apm.13161","volume":"130","author":"K Thomsen","year":"2022","unstructured":"Thomsen K, Kobayashi O, Kishi K et al (2022) Animal models of chronic and recurrent Pseudomonas aeruginosa lung infection: significance of macrolide treatment. APMIS 130:458\u2013476. https:\/\/doi.org\/10.1111\/apm.13161","journal-title":"APMIS"},{"key":"16_CR3","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1111\/apm.13119","volume":"130","author":"AG Bobrov","year":"2022","unstructured":"Bobrov AG, Getnet D, Swierczewski B et al (2022) Evaluation of Pseudomonas aeruginosa pathogenesis and therapeutics in military-relevant animal infection models. APMIS 130:436\u2013457. https:\/\/doi.org\/10.1111\/apm.13119","journal-title":"APMIS"},{"key":"16_CR4","doi-asserted-by":"publisher","unstructured":"Brix A, Cafora M, Aureli M, Pistocchi A (2020) Animal models to translate phage therapy to human medicine. Int J Mol Sci 21. https:\/\/doi.org\/10.3390\/ijms21103715","DOI":"10.3390\/ijms21103715"},{"key":"16_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fcell.2022.899368","volume":"10","author":"V Bos\u00e1kov\u00e1","year":"2022","unstructured":"Bos\u00e1kov\u00e1 V, De Zuani M, Sl\u00e1dkov\u00e1 L et al (2022) Lung organoids\u2014the ultimate tool to dissect pulmonary diseases? Front Cell Dev Biol 10:1\u201319. https:\/\/doi.org\/10.3389\/fcell.2022.899368","journal-title":"Front Cell Dev Biol"},{"key":"16_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fphar.2018.01475","volume":"9","author":"A Semaniakou","year":"2019","unstructured":"Semaniakou A, Croll RP, Chappe V (2019) Animal models in the pathophysiology of cystic fibrosis. Front Pharmacol 9:1\u201316. https:\/\/doi.org\/10.3389\/fphar.2018.01475","journal-title":"Front Pharmacol"},{"key":"16_CR7","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/s13326-019-0209-1","volume":"10","author":"H Pan","year":"2019","unstructured":"Pan H, Deutsch GH, Wert SE (2019) Comprehensive anatomic ontologies for lung development: a comparison of alveolar formation and maturation within mouse and human lung. J Biomed Semantics 10:18. https:\/\/doi.org\/10.1186\/s13326-019-0209-1","journal-title":"J Biomed Semantics"},{"key":"16_CR8","doi-asserted-by":"publisher","first-page":"S193","DOI":"10.1152\/physrev.1999.79.1.S193","volume":"79","author":"BR Grubb","year":"1999","unstructured":"Grubb BR, Boucher RC (1999) Pathophysiology of gene-targeted mouse models for cystic fibrosis. Physiol Rev 79:S193\u2013S214. https:\/\/doi.org\/10.1152\/physrev.1999.79.1.S193","journal-title":"Physiol Rev"},{"key":"16_CR9","doi-asserted-by":"publisher","first-page":"1715","DOI":"10.1042\/CS20200679","volume":"134","author":"M Nandi","year":"2020","unstructured":"Nandi M, Jackson SK, Macrae D et al (2020) Rethinking animal models of sepsis \u2013 working towards improved clinical translation whilst integrating the 3Rs. Clin Sci 134:1715\u20131734. https:\/\/doi.org\/10.1042\/CS20200679","journal-title":"Clin Sci"},{"key":"16_CR10","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1038\/s41576-022-00466-9","volume":"23","author":"DE Ingber","year":"2022","unstructured":"Ingber DE (2022) Human organs-on-chips for disease modelling, drug development and personalized medicine. Nat Rev Genet 23:467\u2013491. https:\/\/doi.org\/10.1038\/s41576-022-00466-9","journal-title":"Nat Rev Genet"},{"key":"16_CR11","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1038\/s41580-020-0259-3","volume":"21","author":"J Kim","year":"2020","unstructured":"Kim J, Koo BK, Knoblich JA (2020) Human organoids: model systems for human biology and medicine. Nat Rev Mol Cell Biol 21:571\u2013584. https:\/\/doi.org\/10.1038\/s41580-020-0259-3","journal-title":"Nat Rev Mol Cell Biol"},{"key":"16_CR12","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1146\/annurev-pathmechdis-012419-032611","volume":"15","author":"F Schutgens","year":"2020","unstructured":"Schutgens F, Clevers H (2020) Human organoids: tools for understanding biology and treating diseases. Annu Rev Pathol Mech Dis 15:211\u2013234. https:\/\/doi.org\/10.1146\/annurev-pathmechdis-012419-032611","journal-title":"Annu Rev Pathol Mech Dis"},{"key":"16_CR13","doi-asserted-by":"publisher","unstructured":"Peng L, Gao L, Wu X et al (2022) Lung organoids as model to study SARS-CoV-2 infection. Cell 11. https:\/\/doi.org\/10.3390\/cells11172758","DOI":"10.3390\/cells11172758"},{"key":"16_CR14","doi-asserted-by":"publisher","unstructured":"Plebani R, Bai H, Si L et al (2022) 3D lung tissue models for studies on SARS-CoV-2 pathophysiology and therapeutics. Int J Mol Sci 23. https:\/\/doi.org\/10.3390\/ijms231710071","DOI":"10.3390\/ijms231710071"},{"key":"16_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/advs.202105187","volume":"9","author":"Y Wang","year":"2022","unstructured":"Wang Y, Wang P, Qin J (2022) Human organoids and organs-on-chips for addressing COVID-19 challenges. Adv Sci 9:1\u201317. https:\/\/doi.org\/10.1002\/advs.202105187","journal-title":"Adv Sci"},{"key":"16_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/ijms22052356","volume":"22","author":"M Trevisan","year":"2021","unstructured":"Trevisan M, Riccetti S, Sinigaglia A, Barzon L (2021) Sars-cov-2 infection and disease modelling using stem cell technology and organoids. Int J Mol Sci 22:1\u201319. https:\/\/doi.org\/10.3390\/ijms22052356","journal-title":"Int J Mol Sci"},{"key":"16_CR17","doi-asserted-by":"publisher","DOI":"10.1016\/j.scr.2021.102207","volume":"53","author":"AM Giani","year":"2021","unstructured":"Giani AM, Chen S (2021) Human pluripotent stem cell-based organoids and cell platforms for modelling SARS-CoV-2 infection and drug discovery. Stem Cell Res 53:102207. https:\/\/doi.org\/10.1016\/j.scr.2021.102207","journal-title":"Stem Cell Res"},{"key":"16_CR18","doi-asserted-by":"publisher","first-page":"3550","DOI":"10.1021\/acs.accounts.1c00411","volume":"54","author":"Y Wang","year":"2021","unstructured":"Wang Y, Wang P, Qin J (2021) Microfluidic organs-on-a-chip for modeling human infectious diseases. Acc Chem Res 54:3550\u20133562. https:\/\/doi.org\/10.1021\/acs.accounts.1c00411","journal-title":"Acc Chem Res"},{"key":"16_CR19","doi-asserted-by":"publisher","unstructured":"Tindle C, Fuller M, Fonseca A et al (2021) Adult stem cell-derived complete lung organoid models emulate lung disease in COVID-19. elife 10:1\u201344. https:\/\/doi.org\/10.7554\/eLife.66417","DOI":"10.7554\/eLife.66417"},{"key":"16_CR20","doi-asserted-by":"publisher","unstructured":"Basu A, Pamreddy A, Singh P, Sharma K (2021) An adverse outcomes approach to study the effects of SARS-CoV-2 in 3D organoid models. J Mol Biol 167213. https:\/\/doi.org\/10.1016\/j.jmb.2021.167213","DOI":"10.1016\/j.jmb.2021.167213"},{"key":"16_CR21","doi-asserted-by":"publisher","first-page":"1586","DOI":"10.1016\/j.cell.2016.05.082","volume":"165","author":"H Clevers","year":"2016","unstructured":"Clevers H (2016) Modeling development and disease with organoids. Cell 165:1586\u20131597. https:\/\/doi.org\/10.1016\/j.cell.2016.05.082","journal-title":"Cell"},{"key":"16_CR22","doi-asserted-by":"publisher","unstructured":"Wu B (Catherine) Haney EF, Akhoundsadegh N, et al (2021) Human organoid biofilm model for assessing antibiofilm activity of novel agents. npj Biofilms Microbiomes 7:1\u201313. doi:https:\/\/doi.org\/10.1038\/s41522-020-00182-4, 8","DOI":"10.1038\/s41522-020-00182-4"},{"key":"16_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-017-12041-y","volume":"7","author":"JPH Smits","year":"2017","unstructured":"Smits JPH, Niehues H, Rikken G et al (2017) Immortalized N\/TERT keratinocytes as an alternative cell source in 3D human epidermal models. Sci Rep 7:1\u201314. https:\/\/doi.org\/10.1038\/s41598-017-12041-y","journal-title":"Sci Rep"},{"key":"16_CR24","doi-asserted-by":"publisher","first-page":"e0240822","DOI":"10.1128\/spectrum.02408-22","volume":"10","author":"M Tang","year":"2022","unstructured":"Tang M, Liao S, Qu J et al (2022) Evaluating bacterial pathogenesis using a model of human airway organoids infected with Pseudomonas aeruginosa biofilms. Microbiol Spectr 10:e0240822. https:\/\/doi.org\/10.1128\/spectrum.02408-22","journal-title":"Microbiol Spectr"},{"key":"16_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.ppat.1009534","volume":"17","author":"C Penaranda","year":"2021","unstructured":"Penaranda C, Chumbler NM, Hung DT (2021) Dual transcriptional analysis reveals adaptation of host and pathogen to intracellular survival of Pseudomonas aeruginosa associated with urinary tract infection. PLoS Pathog 17:1\u201324. https:\/\/doi.org\/10.1371\/journal.ppat.1009534","journal-title":"PLoS Pathog"},{"key":"16_CR26","doi-asserted-by":"publisher","first-page":"1701","DOI":"10.1016\/j.celrep.2019.01.068","volume":"26","author":"G Berkers","year":"2019","unstructured":"Berkers G, van Mourik P, Vonk AM et al (2019) Rectal organoids enable personalized treatment of cystic fibrosis. Cell Rep 26:1701\u20131708.e3. https:\/\/doi.org\/10.1016\/j.celrep.2019.01.068","journal-title":"Cell Rep"},{"key":"16_CR27","doi-asserted-by":"publisher","first-page":"2100908","DOI":"10.1183\/13993003.00908-2021","volume":"58","author":"G Sette","year":"2021","unstructured":"Sette G, Lo CS, Blacon\u00e0 G et al (2021) Theratyping cystic fibrosis in vitro in ALI culture and organoid models generated from patient-derived nasal epithelial conditionally reprogrammed stem cells. Eur Respir J 58:2100908. https:\/\/doi.org\/10.1183\/13993003.00908-2021","journal-title":"Eur Respir J"},{"key":"16_CR28","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1016\/j.jcf.2021.10.004","volume":"21","author":"R Plebani","year":"2022","unstructured":"Plebani R, Potla R, Soong M et al (2022) Modeling pulmonary cystic fibrosis in a human lung airway-on-a-chip. J Cyst Fibros 21:606\u2013615. https:\/\/doi.org\/10.1016\/j.jcf.2021.10.004","journal-title":"J Cyst Fibros"}],"container-title":["Methods in Molecular Biology","Pseudomonas aeruginosa"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-0716-3473-8_16","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,11]],"date-time":"2023-10-11T10:10:31Z","timestamp":1697019031000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-1-0716-3473-8_16"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,12]]},"ISBN":["9781071634721","9781071634738"],"references-count":28,"URL":"https:\/\/doi.org\/10.1007\/978-1-0716-3473-8_16","relation":{},"ISSN":["1064-3745","1940-6029"],"issn-type":[{"value":"1064-3745","type":"print"},{"value":"1940-6029","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,10,12]]},"assertion":[{"value":"12 October 2023","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}